TCF7 and primary cutaneous T-cell non-Hodgkin lymphoma: We identified a TCF7+ Tex signature enriched in TMF, which is consistent with previous reports of TCF7+ malignant T cells in the aggressive molecular subtype of CTCL that included all TMF cases in their cohort (63).